Not Much Strategic Sense To An AstraZeneca-Gilead Deal
June 8, 2020
28 min
Full
1,714 of 3,435
June 8, 2020
Not Much Strategic Sense To An AstraZeneca-Gilead Deal
0:00 / 28:40
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Bloomberg Podcasts Episodes Around June 8, 2020
Episode 1,714 of 3,435 — walk the feed in the order it was published.
28:40This episodeNot Much Strategic Sense To An AstraZeneca-Gilead Deal
Summary
<p>Bloomberg Opinion's Max Nisen, biotech and health care columnist, and Chris Hughes, deals columnist, on AstraZeneca mulling a bid for Gilead. Bill Smead, CEO and CIO of Smead Capital Management, on buying opportunities created by destruction of economic optimism. Banker to the World" Bill Rhodes, President and CEO of William Rhodes Global Advisors, on debt relief for emerging markets. Peter Kolchinsky, founder and Managing Partner at RA Capital Management, discusses investing in biotech for a vaccine. Hosted by Paul Sweeney and Vonnie Quinn.</p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>
Episode details and artwork are published by the show’s own feed. Sentinel plays short cited excerpts and links every episode back to its publisher.